Peter Saunders
Directeur/Membre du Conseil chez Asterion Bio Med, Inc.
Profil
Peter Saunders is the founder of Oryx Pharmaceuticals, Inc. He is currently a Director at Asterion Bio Med, Inc. He was formerly a Director & Director-International Business Affairs at Optima Medical Innovations Corp.
from 2018 to 2020.
He was also a Vice President-Sales at Wayland Group Corp.
Postes actifs de Peter Saunders
| Sociétés | Poste | Début |
|---|---|---|
Asterion Bio Med, Inc.
 Asterion Bio Med, Inc. Medical/Nursing ServicesHealth Services Asterion Bio Med, Inc. provides healthcare services. The firm is a consolidation platform for hospital and independent healthcare facilities. The company was founded on May 02, 2017 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Saunders
| Sociétés | Poste | Fin |
|---|---|---|
| OPTIMA MEDICAL INNOVATIONS CORP. | Directeur/Membre du Conseil | 20/07/2020 |
| WAYLAND GROUP CORP. | Sales & Marketing | 13/02/2018 |
Oryx Pharmaceuticals, Inc.
 Oryx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Oryx Pharmaceuticals, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Mississauga, Canada. Oryx Pharmaceuticals was acquired by Sumitomo Pharma America, Inc., part of Sumitomo Chemical Co., Ltd. from October 20, 2009 on June 03, 2008 for $70 million. The company was founded by Peter Saunders. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WAYLAND GROUP CORP. | Process Industries |
| OPTIMA MEDICAL INNOVATIONS CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oryx Pharmaceuticals, Inc.
Oryx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Oryx Pharmaceuticals, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Mississauga, Canada. Oryx Pharmaceuticals was acquired by Sumitomo Pharma America, Inc., part of Sumitomo Chemical Co., Ltd. from October 20, 2009 on June 03, 2008 for $70 million. The company was founded by Peter Saunders. | Health Technology |
Asterion Bio Med, Inc.
Asterion Bio Med, Inc. Medical/Nursing ServicesHealth Services Asterion Bio Med, Inc. provides healthcare services. The firm is a consolidation platform for hospital and independent healthcare facilities. The company was founded on May 02, 2017 and is headquartered in Toronto, Canada. | Health Services |
